Gilead Sciences Declares First Quarterly Cash Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)--Apr. 30, 2015-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a quarterly cash dividend of $0.43 per share of common stock, to be paid on the payment date of June 29, 2015 to all stockholders of record as of the close of business on the record date of June 16, 2015. This is the first quarterly dividend declared under the Board's dividend program announced on February 3, 2015. Future dividends will be subject to Board approval.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations